HARVEY J YORKER
Allopathic & Osteopathic Physicians|Urology PHILA, PA NPI 1982603080
Browse related groups: Allopathic & Osteopathic Physicians|Urology PA Corcept Therapeutics All categories
General Payments — all program years on this page
$2,206.96
- Category: General Payments
- Program years: PY2018–2024
- Record count: 25
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $815.10 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $815.10 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Corcept Therapeutics | $228.33 | 2 |
| Novo Nordisk AS | $136.29 | 2 |
| ITI, Inc. | $124.99 | 1 |
| Amgen Inc. | $120.29 | 1 |
| ABBVIE INC. | $113.46 | 1 |
| Lilly USA, LLC | $91.74 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1097641090 | Novo Nordisk Inc | $115.74 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097811748 | Novo Nordisk Inc | $20.55 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1106379266 | ABBVIE INC. | $113.46 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1111744742 | Amgen Inc. | $120.29 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117794238 | Corcept Therapeutics | $101.30 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1117794316 | Corcept Therapeutics | $127.03 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1135015904 | Lilly USA, LLC | $91.74 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143348601 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $124.99 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.